MetLife Enterprise Value vs Free Cash Flow Analysis

MET Stock

USD 72.22 0.26 0.36%

MetLife financial indicator trend analysis is infinitely more than just investigating MetLife recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MetLife is a good investment. Please check the relationship between MetLife Enterprise Value and its Free Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.

Enterprise Value vs Free Cash Flow

Enterprise Value vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MetLife Enterprise Value account and Free Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between MetLife's Enterprise Value and Free Cash Flow is 0.47. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of MetLife, assuming nothing else is changed. The correlation between historical values of MetLife's Enterprise Value and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of MetLife are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Enterprise Value i.e., MetLife's Enterprise Value and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.47

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Enterprise Value

Enterprise Value (or EV) is usually referred to as MetLife theoretical takeover price. In the event of an acquisition, an acquirer would have to take on MetLife debt, but would also pocket its cash. Enterprise Value is more accurate representation of MetLife value than its market capitalization because it takes into account all of MetLife existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from MetLife's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MetLife current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.At this time, MetLife's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 21.48 in 2024, whereas Selling General Administrative is likely to drop slightly above 5.8 B in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	71.1B	69.9B	66.4B	52.8B
Total Revenue	71.1B	69.9B	66.4B	52.8B

Gross Profit Total Revenue

MetLife fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Other Liab	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Inventory
Common Stock Shares Outstanding		0.76	0.62	0.85	0.85	0.75	0.69	-0.12	-0.25	-0.22	0.39	-0.5	0.92	0.75	0.08	-0.47	-0.23	-0.42	0.58	0.51	-0.16	0.42	0.56	0.09	0.41	0.66
Total Assets	0.76		0.77	0.5	0.49	0.82	0.4	0.51	0.35	-0.13	0.7	-0.2	0.85	1.0	0.24	-0.85	0.15	-0.3	0.47	0.27	0.1	0.73	0.89	0.62	0.7	0.17
Short Long Term Debt Total	0.62	0.77		0.44	0.44	0.54	0.69	0.29	0.18	-0.16	0.16	-0.04	0.68	0.78	0.57	-0.66	-0.07	-0.27	0.01	-0.04	0.57	0.66	0.88	0.43	0.16	0.19
Other Current Liab	0.85	0.5	0.44		1.0	0.43	0.74	-0.29	-0.43	-0.13	0.18	-0.56	0.81	0.49	-0.09	-0.15	-0.42	-0.32	0.57	0.67	-0.15	0.33	0.31	-0.08	0.19	0.88
Total Current Liabilities	0.85	0.49	0.44	1.0		0.43	0.74	-0.29	-0.43	-0.13	0.17	-0.57	0.81	0.49	-0.09	-0.14	-0.42	-0.32	0.57	0.67	-0.15	0.33	0.3	-0.08	0.19	0.88
Total Stockholder Equity	0.75	0.82	0.54	0.43	0.43		0.33	0.26	0.19	-0.42	0.6	-0.58	0.81	0.79	0.17	-0.58	0.14	-0.6	0.58	0.2	-0.19	0.37	0.67	0.34	0.61	0.35
Net Debt	0.69	0.4	0.69	0.74	0.74	0.33		-0.31	-0.54	-0.33	-0.2	-0.43	0.66	0.4	0.33	-0.07	-0.61	-0.44	0.14	0.2	0.3	0.25	0.41	-0.17	-0.19	0.69
Retained Earnings	-0.12	0.51	0.29	-0.29	-0.29	0.26	-0.31		0.84	0.19	0.58	0.3	0.11	0.53	0.04	-0.66	0.62	0.17	0.14	-0.08	0.31	0.5	0.57	0.83	0.56	-0.54
Cash	-0.25	0.35	0.18	-0.43	-0.43	0.19	-0.54	0.84		0.15	0.55	0.34	-0.02	0.36	0.18	-0.61	0.7	0.16	-0.07	-0.27	0.19	0.42	0.47	0.78	0.52	-0.61
Other Assets	-0.22	-0.13	-0.16	-0.13	-0.13	-0.42	-0.33	0.19	0.15		-0.09	0.59	-0.35	-0.09	-0.37	0.0	0.45	0.96	-0.04	0.25	0.12	0.24	-0.28	0.11	-0.09	-0.33
Cash And Short Term Investments	0.39	0.7	0.16	0.18	0.17	0.6	-0.2	0.58	0.55	-0.09		-0.13	0.53	0.7	-0.09	-0.72	0.37	-0.2	0.52	0.28	-0.4	0.46	0.53	0.65	1.0	-0.09
Non Current Liabilities Total	-0.5	-0.2	-0.04	-0.56	-0.57	-0.58	-0.43	0.3	0.34	0.59	-0.13		-0.59	-0.15	0.05	-0.22	0.31	0.72	-0.56	-0.27	0.43	0.18	-0.05	0.3	-0.14	-0.81
Other Stockholder Equity	0.92	0.85	0.68	0.81	0.81	0.81	0.66	0.11	-0.02	-0.35	0.53	-0.59		0.83	0.14	-0.55	-0.16	-0.55	0.61	0.44	-0.12	0.5	0.72	0.28	0.53	0.62
Total Liab	0.75	1.0	0.78	0.49	0.49	0.79	0.4	0.53	0.36	-0.09	0.7	-0.15	0.83		0.24	-0.87	0.15	-0.26	0.44	0.27	0.13	0.76	0.89	0.64	0.7	0.15
Total Current Assets	0.08	0.24	0.57	-0.09	-0.09	0.17	0.33	0.04	0.18	-0.37	-0.09	0.05	0.14	0.24		-0.23	-0.32	-0.31	-0.66	-0.77	0.53	0.17	0.43	-0.01	-0.1	-0.1
Short Term Debt	-0.47	-0.85	-0.66	-0.15	-0.14	-0.58	-0.07	-0.66	-0.61	0.0	-0.72	-0.22	-0.55	-0.87	-0.23		-0.4	0.1	-0.23	-0.11	-0.18	-0.73	-0.87	-0.82	-0.71	0.25
Other Liab	-0.23	0.15	-0.07	-0.42	-0.42	0.14	-0.61	0.62	0.7	0.45	0.37	0.31	-0.16	0.15	-0.32	-0.4		0.39	0.23	0.09	-0.08	0.22	0.16	0.6	0.36	-0.52
Accounts Payable	-0.42	-0.3	-0.27	-0.32	-0.32	-0.6	-0.44	0.17	0.16	0.96	-0.2	0.72	-0.55	-0.26	-0.31	0.1	0.39		-0.23	0.08	0.2	0.09	-0.39	0.04	-0.2	-0.49
Non Current Assets Total	0.58	0.47	0.01	0.57	0.57	0.58	0.14	0.14	-0.07	-0.04	0.52	-0.56	0.61	0.44	-0.66	-0.23	0.23	-0.23		0.85	-0.53	0.2	0.2	0.24	0.53	0.5
Non Currrent Assets Other	0.51	0.27	-0.04	0.67	0.67	0.2	0.2	-0.08	-0.27	0.25	0.28	-0.27	0.44	0.27	-0.77	-0.11	0.09	0.08	0.85		-0.43	0.25	0.01	0.13	0.3	0.52
Long Term Debt	-0.16	0.1	0.57	-0.15	-0.15	-0.19	0.3	0.31	0.19	0.12	-0.4	0.43	-0.12	0.13	0.53	-0.18	-0.08	0.2	-0.53	-0.43		0.29	0.35	0.2	-0.42	-0.26
Net Receivables	0.42	0.73	0.66	0.33	0.33	0.37	0.25	0.5	0.42	0.24	0.46	0.18	0.5	0.76	0.17	-0.73	0.22	0.09	0.2	0.25	0.29		0.69	0.76	0.46	-0.02
Good Will	0.56	0.89	0.88	0.31	0.3	0.67	0.41	0.57	0.47	-0.28	0.53	-0.05	0.72	0.89	0.43	-0.87	0.16	-0.39	0.2	0.01	0.35	0.69		0.71	0.52	0.01
Common Stock Total Equity	0.09	0.62	0.43	-0.08	-0.08	0.34	-0.17	0.83	0.78	0.11	0.65	0.3	0.28	0.64	-0.01	-0.82	0.6	0.04	0.24	0.13	0.2	0.76	0.71		0.63	-0.4
Short Term Investments	0.41	0.7	0.16	0.19	0.19	0.61	-0.19	0.56	0.52	-0.09	1.0	-0.14	0.53	0.7	-0.1	-0.71	0.36	-0.2	0.53	0.3	-0.42	0.46	0.52	0.63		-0.08
Inventory	0.66	0.17	0.19	0.88	0.88	0.35	0.69	-0.54	-0.61	-0.33	-0.09	-0.81	0.62	0.15	-0.1	0.25	-0.52	-0.49	0.5	0.52	-0.26	-0.02	0.01	-0.4	-0.08

Click cells to compare fundamentals

MetLife Account Relationship Matchups

MetLife fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	944.4M	913.2M	869.4M	808.9M	762.3M	954.7M
Total Assets	740.5B	795.1B	759.7B	666.6B	687.6B	656.2B
Short Long Term Debt Total	16.9B	18.1B	17.4B	18.0B	18.8B	18.1B
Other Current Liab	(235M)	(393M)	(341M)	(2.8B)	190M	180.5M
Total Current Liabilities	235M	393M	341M	217M	309M	293.6M
Total Stockholder Equity	66.1B	74.6B	67.5B	27.0B	30.0B	46.4B
Net Debt	253M	(1.6B)	(2.6B)	(2.2B)	(1.8B)	(1.7B)
Retained Earnings	33.1B	36.5B	41.2B	42.0B	40.1B	24.7B
Cash	16.6B	19.8B	20.0B	20.2B	20.6B	12.6B
Other Assets	8.6B	6.1B	(10.1B)	357.5B	373.7B	392.4B
Cash And Short Term Investments	348.3B	378.5B	367.5B	301.9B	308.1B	188.5B
Liabilities And Stockholders Equity	740.5B	795.1B	759.7B	666.6B	687.6B	656.2B
Non Current Liabilities Total	25.7B	28.8B	26.8B	639.1B	657.0B	689.9B
Other Stockholder Equity	20.0B	20.0B	15.4B	12.2B	9.1B	8.6B
Total Liab	674.1B	720.3B	692.0B	639.3B	657.3B	609.5B
Total Current Assets	368.7B	396.4B	384.8B	297.0B	302.1B	286.7B
Accumulated Other Comprehensive Income	13.1B	18.1B	10.9B	(27.1B)	(19.2B)	(18.3B)
Short Term Debt	268M	235M	393M	341M	119M	113.1M
Other Liab	548.5B	663.5B	633.0B	512.5B	589.3B	618.8B
Accounts Payable	363M	129M	2.2B	20.8B	18.7B	19.7B
Non Current Assets Total	363.1B	392.7B	385.0B	12.1B	11.8B	11.3B
Non Currrent Assets Other	(363.1B)	(392.7B)	(385.0B)	(309.3B)	(164.7B)	(173.0B)
Long Term Debt	4.1B	4.0B	17.1B	17.8B	18.7B	13.0B
Net Receivables	20.4B	17.9B	17.3B	17.5B	29.2B	18.7B
Good Will	9.3B	10.1B	9.5B	9.3B	9.2B	7.7B
Short Term Investments	331.7B	358.7B	347.5B	281.7B	287.5B	190.6B
Inventory	(62.4B)	(59.9B)	(55.4B)	(104.3B)	(93.9B)	(89.2B)
Treasury Stock	(12.7B)	(13.8B)	(18.2B)	(21.5B)	(19.3B)	(18.3B)
Intangible Assets	19.1B	18.7B	18.3B	25.5B	20.9B	12.2B
Property Plant Equipment	2.8B	2.6B	2.2B	1.9B	2.1B	1.5B
Property Plant And Equipment Net	354.0B	381.7B	375.3B	1.9B	(148.6B)	(141.2B)
Other Current Assets	62.4B	59.9B	55.4B	(22.4B)	69.1B	97.5B
Noncontrolling Interest In Consolidated Entity	238M	259M	267M	247M	284.1M	303.9M
Retained Earnings Total Equity	33.1B	36.5B	41.2B	42.0B	48.2B	30.2B
Deferred Long Term Liab	9.1B	11.0B	9.7B	325M	373.8M	355.1M
Net Tangible Assets	56.8B	64.4B	57.9B	17.7B	16.0B	15.2B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether MetLife is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if MetLife Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Metlife Stock. Highlighted below are key reports to facilitate an investment decision about Metlife Stock:

How To Invest In MetLife

Details

Is MetLife Stock a good investment?

Details

What is MetLife's Net Worth?

Details

Largest Life & Health Insurance Companies

View

Largest Insurance - Life Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.

Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for MetLife Stock analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.

	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Global Correlations Find global opportunities by holding instruments from different markets

Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.61)

Dividend Share

2.06

Earnings Share

1.81

Revenue Per Share

88.295

Quarterly Revenue Growth

0.219

The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

MetLife Enterprise Value vs Free Cash Flow Analysis

Enterprise Value vs Free Cash Flow

Enterprise Value vs Free Cash Flow Correlation Analysis

Correlation Coefficient

Enterprise Value

Free Cash Flow

MetLife fundamental ratios Correlations

MetLife Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MetLife fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for MetLife Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Short Term Investments	+ 1.0	Cash And Short Term Investments
Accounts Payable	+ 0.96	Other Assets
Other Stockholder Equity	+ 0.92	Common Stock Shares Outstanding
Good Will	+ 0.89	Total Assets

Good Will	- 0.87	Short Term Debt
Short Term Debt	- 0.87	Total Liab
Short Term Debt	- 0.85	Total Assets
Common Stock Total Equity	- 0.82	Short Term Debt
Inventory	- 0.81	Non Current Liabilities Total
Non Currrent Assets Other	- 0.77	Total Current Assets